Mark Levin's First Two Deals at Third Rock
Today, Todd Wallack of the Globe gets a bit more in depth with Constellation, noting that the firm has raised $32 million, and that Levin will serve as interim CEO (though he's recruiting a permanent chief executive.) Wallack also mentions that Third Rock has backed another company, Zafgen, which is hunting for treatments for obesity. That company has raised $23 million.
Here's the official press release on Constellation.
(Still no news of either company on the Third Rock Web site.)
Labels: Constellation Pharmaceuticals, Mark Levin, Third Rock Ventures, Zafgen